According to the 2020 Italian guidelines, long-acting dihydropyridine calcium antagonists, alpha-blockers (doxazosin) and/or moxonidine should be used to control hypertension for 4–6 weeks before measuring the ARR because these drugs minimally affect renin and PAC. The gene discussed is REN; the disease is Hypertension.